• eu
  • es
  • en
  • Molecular Imaging Facility – CIC biomaGUNE

    The integrated imaging facility offers state-of-the-art imaging resources in Positron Emission Tomography (PET), Single Photon Emission Computerized Tomography (SPECT), Computerized Tomography (CT), Magnetic Resonance Imaging (MRI) and animal facilities to perform preclinical animal testing of different formulations and implantable devices, and development of contrast agents. The use of radiolabelled molecules and MRI contrast agents allows to perform metabolic tests and ADME (adsorption, distribution, metabolism and excretion) in rodents by PET and MRI.


    • Animal Facility
    • Bruker · Magnetic Resonance Imaging System · Biospec 117/16 USR
    • Bruker · Minispec mq60
    • IBA 18/9 · Cyclotron
    • Molecubes · Trimodal PET/SPET/CT System

    Fields of application

    Biomedical consumables

    Electromedical devices

    Medical Image

    Orthopedic and rehabilitation Technology


    Development of healing devices in animal model

    Carrying out animal experimentation projects in accordance with the AALAC animal welfare protection regulations We offer the licensing management services in animal experimentation and procedures to perform in vivo experimental proposals.

    Evaluation of the effect of compounds in longitudinal animla model

    We offer the possibility to perform long term animal studies to evaluate the effect of compounds during the development of certain diseases.

    Preclinical MRI Imaging in rodents

    Assessment of MRI studies in rodents with an MRI 11.7 Tesla magnet, operating at a proton resonance frequency of 500MHz (actively shielded ultra refrigerated superconducting).

    Preclinical PET SPECT Imaging in rodents

    Assessment of in vivo and ex vivo nuclear imaging studies of in-house produced radiolabelled compound or suspension. We offer a state-of-the-art imaging resources in Positron Emission Tomography (PET), Single Photon Emission Computerized Tomography (SPECT) and X ray Computerized Tomography (CT).

    Synthesis and labelling of radiotracer for pharmacokinetics/dynamic studies.

    The facility allows the synthesis of a wide range of PET and SPECT radiotracers, as well as the design of new labelled structures to undertake pharmacokinetic and pharmacodynamic studies. Offer the analyse of radiolabelled metabolites in blood, tissue samples, cell culture, biomolecules, suspension or devices.


    Asociacion Centro de Investigación Cooperativa en Biomateriales · CIC biomaGUNE
    Contact person:
    Angel Martínez